参 考 文 献
[1] Mc Neish IA, Bell SJ, Lemoine NR. Gene therapy progress and prospects: cancer gene therapy usingtumour suppress or genes. Gen Ther, 2004, 11 (6): 497.
[2] Ho EA，Ramsay E，Ginj M，et al. Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties[J].J Pharm Sci，2010，99(6）：2839.
[3] Kim H，Davaa E，Myung C，et al. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid[J].Int J Pharm，2010，392：141.
[4] Kuesters GM，Campbell RB. Conjugation of bevacizumab to cationicliposomes enhances their tumor-targeting potential[J]. Nanomedicine (Lond），2010,5(2)：181.
[5] Pirollo KF, Zon G, Rait A, et al. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery[J].Hum Gene Ther，2006，17(1）：117.
[6] Wang H，Zhao P，Liang X，et al. Folate-PEG coated cationic modified chitosan -Cholesterol liposomes for tumor-targeted drug delivery[J]. Biomaterials，2010，31(14）：4129.
[7] Pirollo KF，Rait A，Zhou Q，et al. Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo[J]. Clin Cancer Res，2008，14(7)：2190.
[8] Chunmao Wang, Chao Ding, Minjian Kong, et al. Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo[J]. Bioch and Biophy Res Commun，2011(Received).
[9] Azam Bolhassani, Shima Safaiyan, Sima Rafati. Improvement of different vaccine delivery systems for cancer therapy. Molecular Cancer 2011, 10:3.
[10] 孙逊,田聆,聂宇等，阳离子脂质体-DNA复合物与脂质-鱼精蛋白-DNA复合物体外细胞转染率比较[J], 生物医学工程学杂志，2007，24（1）：191.
[11] Chen J, Yu H, Chen H, et al. Transfection efficiency and intracellular fate of polycation liposomes combined with protamine[J]. Biomaterials, 2011, 32(5):1412.
[12] Torchilin VP. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery[J].Biopolymers，2008，90(5)：604.
[13] Tseng YL，Liu JJ，Hong RL.Translocation of liposomes into cancer cellsby cell-penetrating peptides penetratin and tat：a kinetic and efficacy study[J]. Mol Pharmacol，2002，62(4）：864.
[14] Gupta B，Levchenko TS，Torchilin VP.TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor Xenografts in nude mice[J]. Oncol Res，2007，16(8）：351.
[15] Zhang C，Tang N，Liu X，et al. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene[J]. J Control Release, 2006，112(2)：229.
[16] Li Qiang，Jin Yi，Cui Fu-de．Study on melanoma vaccine using membrane fusogenic 1iposomes as the vector[J]．Chin Pharm J，2003，38(11)：851．
[17] 孙瑞琳，金发光，吴道澄等，多聚胺阳离子脂质体转染效率及细胞毒性的评价[J]，解放军医学杂志，2006，31（4）：327.
[18] Sawant RM，Hurley JP，Salmaso S，et al. “SMART”drug delivery systems：double-targeted pH-responsive pharmaceutical nanocarriers[J]. BioconjugChem，2006，17(4）：943.
百度搜索“77cn”或“免费范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读，免费范文网，提供经典小说医药类新型脂质体用于肿瘤基因治疗中的研究进展(3)在线全文阅读。
